Dravet Syndrome
Also known as: Dravet Syndrome (DS) / Dravet syndrome, intractable, without status epilepticus / Severe myoclonic epilepsy of infancy / Epilepsy, Myoclonic, Infantile, Severe / Severe myoclonic epilepsy in infancy (disorder)
| Drug | Drug Name | Drug Description |
|---|---|---|
| DB09061 | Cannabidiol | An active cannabinoid used as an adjunctive treatment for the management of seizures associated with Lennox-Gastaut syndrome or Dravet syndrome and symptomatic relief of moderate to severe neuropathic pain or other painful conditions, like cancer. |
| DB00349 | Clobazam | A benzodiazepine used as adjunct treatment in seizures associated with Lennox-Gastaut syndrome. |
| DB00574 | Fenfluramine | Fenfluramine is a phenethylamine that is structurally similar to serotonin. Due to its ability to increase extracellular serotonin levels, modulate serotonergic and other neurologic receptors, and control neurotransmission, it is effective in treating pharmacoresistant seizures. |
| DB09118 | Stiripentol | An antiepileptic agent used in combination with other anticonvulsants to treat seizures associated with Dravet syndrome. |